Global Central Nervous System Partnering 2010-2017: Deal trends, players and financials

Publisher Name :
Date: 01-Mar-2017
No. of pages: 600
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

Summary

The Global Central Nervous System Partnering 2010 to 2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the central nervous system (cns) partnering deals and agreements entered into by the worlds leading healthcare companies

Global Central Nervous System Partnering 2010 to 2017 provides the full collection of Central Nervous System disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Trends in Central Nervous System partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Central Nervous System partnering agreement structure

Central Nervous System partnering contract documents

Top Central Nervous System deals by value

Most active Central Nervous System dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Central Nervous System disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Central Nervous System deals.

The report presents financial deal terms values for Central Nervous System deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Central Nervous System dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Central Nervous System dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Central Nervous System deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Central Nervous System dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Central Nervous System deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Central Nervous System partnering deals by specific Central Nervous System target announced since 2010. The chapter is organized by specific Central Nervous System therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Central Nervous System partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Central Nervous System partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Central Nervous System technologies and products.

Report scope

Global Central Nervous System Partnering 2010 to 2017 is intended to provide the reader with an in-depth understanding and access to Central Nervous System trends and structure of deals entered into by leading companies worldwide.

Global Central Nervous System Partnering 2010 to 2017 includes:

Trends in Central Nervous System dealmaking in the biopharma industry since 2010

Analysis of Central Nervous System deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Central Nervous System deal contract documents

Comprehensive access to over 3500 Central Nervous System deal records

The leading Central Nervous System deals by value since 2010

Most active Central Nervous System dealmakers since 2010

The report includes deals for the following indications: Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig's Disease, Multiple sclerosis, Nausea, Neuropathy, Pain, Neuralgia, Fibromyalgia, Paralysis, Parkinson's disease, Restless leg syndrome, Spinal cord, Stroke, Stuttering, Traumatic Brain Injury, Vertigo, Weakness, plus other CNS indications.

In Global Central Nervous System Partnering 2010 to 2017, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Central Nervous System Partnering 2010-2017 report provides comprehensive access to available deals and contract documents for over 1,500 central nervous system deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Benefits

Global Central Nervous System Partnering 2010 to 2017 provides the reader with the following key benefits:

In-depth understanding of Central Nervous System deal trends since 2010

Access Central Nervous System deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Central Nervous System partner companies

Comprehensive access to over 750 links to actual Central Nervous System deals entered into by the world's biopharma companies

Indepth review of Central Nervous System deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Central Nervous System opportunities

Uncover companies actively partnering Central Nervous System opportunities

Global Central Nervous System Partnering 2010-2017: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Central Nervous System dealmaking

2.1. Introduction
2.2. Central Nervous System partnering over the years
2.3. Central Nervous System partnering by deal type
2.4. Central Nervous System partnering by industry sector
2.5. Central Nervous System partnering by stage of development
2.6. Central Nervous System partnering by technology type
2.7. Central Nervous System partnering by therapeutic indication

Chapter 3 -Financial deal terms for Central Nervous System partnering

3.1. Introduction
3.2. Disclosed financials terms for Central Nervous System partnering
3.3. Central Nervous System partnering headline values
3.4. Central Nervous System deal upfront payments
3.5. Central Nervous System deal milestone payments
3.6. Central Nervous System royalty rates

Chapter 4 - Leading Central Nervous System deals and dealmakers

4.1. Introduction
4.2. Most active in Central Nervous System partnering
4.3. List of most active dealmakers in Central Nervous System
4.4. Top Central Nervous System deals by value

Chapter 5 - Central Nervous System contract document directory

5.1. Introduction
5.2. Central Nervous System partnering deals where contract document available

Chapter 6 - Central Nervous System dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Central Nervous System therapeutic target

Appendices

Appendix 1 - Directory of Central Nervous System deals by company A-Z 2010 to 2017
Appendix 2 - Directory of Central Nervous System deals by deal type 2010 to 2017
Appendix 3 - Directory of Central Nervous System deals by stage of development 2010 to 2017
Appendix 4 - Directory of Central Nervous System deals by technology type 2010 to 2017
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Figures

Figure 1: Central Nervous System partnering since 2010
Figure 2: Central Nervous System partnering by deal type since 2010
Figure 3: Central Nervous System partnering by industry sector since 2010
Figure 4: Central Nervous System partnering by stage of development since 2010
Figure 5: Central Nervous System partnering by technology type since 2010
Figure 6: Central Nervous System partnering by indication since 2010
Figure 7: Central Nervous System deals with a headline value
Figure 8: Central Nervous System deals with upfront payment values
Figure 9: Central Nervous System deals with milestone payment
Figure 10: Central Nervous System deals with royalty rates
Figure 11: Active Central Nervous System dealmaking activity- 2010 to 2017
Figure 12: Top Central Nervous System deals by value since 2010
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Asia-Pacific Dental Bonding Agents Market Report 2017
    Published: 26-Apr-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the Asia-Pacific Dental Bonding Agents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Dental Bonding Agents for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Global Dental Care Sales Market Report 2017
    Published: 26-Apr-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the global Dental Care market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Dental Care for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Sou......
  • Global Zirconium Dental Implants Sales Market Report 2017
    Published: 30-Mar-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the global Zirconium Dental Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Zirconium Dental Implants for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Dental Bonding Agents Sales Market Report 2017
    Published: 29-Mar-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the global Dental Bonding Agents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Dental Bonding Agents for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - J......
  • Periodontitis - Pipeline Review, H1 2017
    Published: 22-Mar-2017        Price: US 2000 Onwards        Pages: 48
    Periodontitis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Periodontitis - Pipeline Review, H1 2017, provides an overview of the Periodontitis (Mouth And Dental Disorders) pipeline landscape. Periodontitis is a gum infection that damages the soft tissue and destroys the bone that supports teeth. Signs and symptoms of periodontitis include swollen gums, bright red or purplish gum......
  • Global Oral Health Partnering 2010 to 2017
    Published: 01-Mar-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access to the oral health partnering deals and agreements entered into by the worlds leading healthcare companies . The Global Oral Health Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals......
  • Global Dental Partnering 2010-2017: Deal trends, players and financials
    Published: 01-Mar-2017        Price: US 2995 Onwards        Pages: 200
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Dental Partnering 2010-2017: Deal trends, players and financialsreport provides comprehensive understanding and unprecedented access to the dental partnering deals and agreements entered into by the worlds leading healthcare companies Global Dental Partnering 2010 to 2017 provides the full collection of Dental disease deals signed between the world's pharmaceutical and biote......
  • 2017 Top 5 Titanium Dental Implants Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 20-Jan-2017        Price: US 4960 Onwards        Pages: 135
    "This report will be delivered in 2-3 business days after the order is placed." This report studies Titanium Dental Implants in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Titanium Dental Implants Players in each region, with sales, price, revenue and market share for top 5 manufacturer, covering - Straumann - Nobel Biocare (Danaher) - Dentsply/Astra - B......
  • 2017-2022 Global Top Countries Titanium Dental Implants Market Report
    Published: 20-Jan-2017        Price: US 4960 Onwards        Pages: 135
    "This report will be delivered in 2-3 business days after the order is placed." This report studies Titanium Dental Implants in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering - Straumann - Nobel Biocare (Danaher) - Dentsply/Astra - Biom......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs